Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patient Care Planning | 13 | 2019 | 58 | 5.530 |
Why?
|
Delivery of Health Care | 14 | 2020 | 160 | 4.520 |
Why?
|
Organizational Innovation | 11 | 2020 | 31 | 3.790 |
Why?
|
Health Services Research | 11 | 2020 | 82 | 3.460 |
Why?
|
Neoplasms | 16 | 2018 | 726 | 3.060 |
Why?
|
Health Plan Implementation | 6 | 2018 | 22 | 2.160 |
Why?
|
Continuity of Patient Care | 5 | 2019 | 69 | 2.150 |
Why?
|
Survivors | 8 | 2017 | 163 | 2.030 |
Why?
|
Aftercare | 6 | 2019 | 33 | 1.870 |
Why?
|
Evidence-Based Practice | 3 | 2018 | 28 | 1.840 |
Why?
|
Health Services Needs and Demand | 6 | 2019 | 81 | 1.810 |
Why?
|
Administrative Personnel | 2 | 2019 | 2 | 1.310 |
Why?
|
Diffusion of Innovation | 5 | 2019 | 34 | 1.290 |
Why?
|
Attitude of Health Personnel | 4 | 2020 | 183 | 1.200 |
Why?
|
Technology Transfer | 2 | 2017 | 3 | 1.120 |
Why?
|
Leadership | 6 | 2020 | 37 | 1.100 |
Why?
|
Health Facility Administrators | 3 | 2016 | 3 | 1.090 |
Why?
|
Palliative Care | 4 | 2019 | 52 | 1.070 |
Why?
|
Humans | 51 | 2020 | 32005 | 1.040 |
Why?
|
Referral and Consultation | 4 | 2019 | 141 | 1.010 |
Why?
|
Biomedical Research | 2 | 2017 | 156 | 0.980 |
Why?
|
Professional Role | 3 | 2019 | 19 | 0.850 |
Why?
|
Models, Theoretical | 3 | 2018 | 137 | 0.820 |
Why?
|
Quality of Health Care | 3 | 2018 | 147 | 0.780 |
Why?
|
Models, Organizational | 1 | 2020 | 15 | 0.730 |
Why?
|
Information Dissemination | 2 | 2018 | 52 | 0.720 |
Why?
|
Interviews as Topic | 6 | 2019 | 263 | 0.700 |
Why?
|
Health Care Surveys | 3 | 2019 | 185 | 0.700 |
Why?
|
Hospices | 1 | 2019 | 5 | 0.670 |
Why?
|
Health Services Accessibility | 2 | 2013 | 241 | 0.650 |
Why?
|
Urologic Neoplasms | 1 | 2018 | 14 | 0.610 |
Why?
|
Cooperative Behavior | 1 | 2018 | 81 | 0.600 |
Why?
|
Social Support | 2 | 2018 | 181 | 0.600 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 217 | 0.600 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 215 | 0.570 |
Why?
|
Child Abuse | 1 | 2017 | 27 | 0.570 |
Why?
|
Health Personnel | 2 | 2014 | 121 | 0.550 |
Why?
|
United States | 10 | 2019 | 3939 | 0.550 |
Why?
|
Survival Rate | 2 | 2015 | 877 | 0.530 |
Why?
|
Practice Management, Medical | 1 | 2016 | 8 | 0.530 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 510 | 0.510 |
Why?
|
Electronic Health Records | 1 | 2015 | 162 | 0.470 |
Why?
|
Medical Oncology | 3 | 2019 | 86 | 0.440 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 407 | 0.400 |
Why?
|
Qualitative Research | 4 | 2020 | 167 | 0.390 |
Why?
|
Patient Acceptance of Health Care | 1 | 2013 | 172 | 0.380 |
Why?
|
Patient Education as Topic | 1 | 2013 | 271 | 0.380 |
Why?
|
Dental Caries | 2 | 2019 | 22 | 0.330 |
Why?
|
Models, Economic | 1 | 2009 | 20 | 0.330 |
Why?
|
Health Care Costs | 1 | 2009 | 118 | 0.300 |
Why?
|
Female | 14 | 2020 | 19959 | 0.290 |
Why?
|
Male | 13 | 2020 | 19165 | 0.290 |
Why?
|
Patient Care Team | 2 | 2020 | 129 | 0.290 |
Why?
|
Motivation | 2 | 2019 | 112 | 0.270 |
Why?
|
Utilization Review | 2 | 2018 | 17 | 0.270 |
Why?
|
Communication | 2 | 2017 | 142 | 0.260 |
Why?
|
Program Evaluation | 2 | 2019 | 185 | 0.260 |
Why?
|
Cross-Sectional Studies | 3 | 2014 | 1531 | 0.260 |
Why?
|
Physician-Patient Relations | 2 | 2017 | 185 | 0.250 |
Why?
|
Program Development | 2 | 2017 | 96 | 0.240 |
Why?
|
Group Processes | 2 | 2020 | 15 | 0.220 |
Why?
|
Retrospective Studies | 5 | 2018 | 3509 | 0.220 |
Why?
|
Sweden | 2 | 2020 | 14 | 0.210 |
Why?
|
Silver Compounds | 2 | 2019 | 2 | 0.210 |
Why?
|
Quaternary Ammonium Compounds | 2 | 2019 | 7 | 0.210 |
Why?
|
North Carolina | 4 | 2019 | 1514 | 0.200 |
Why?
|
Child, Preschool | 3 | 2019 | 1269 | 0.200 |
Why?
|
Child | 4 | 2019 | 2438 | 0.190 |
Why?
|
Infant, Newborn | 2 | 2017 | 671 | 0.190 |
Why?
|
Delphi Technique | 1 | 2020 | 40 | 0.180 |
Why?
|
Infant | 2 | 2017 | 1061 | 0.180 |
Why?
|
Pilot Projects | 2 | 2019 | 545 | 0.180 |
Why?
|
Crowding | 1 | 2019 | 8 | 0.170 |
Why?
|
Organizational Policy | 1 | 2019 | 20 | 0.170 |
Why?
|
Cariostatic Agents | 1 | 2019 | 4 | 0.170 |
Why?
|
Patient Care | 1 | 2019 | 30 | 0.170 |
Why?
|
Decision Support Techniques | 1 | 2020 | 128 | 0.160 |
Why?
|
Home Care Services | 1 | 2019 | 51 | 0.160 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 90 | 0.160 |
Why?
|
Canada | 1 | 2018 | 56 | 0.150 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 423 | 0.150 |
Why?
|
Goals | 2 | 2016 | 36 | 0.150 |
Why?
|
Internationality | 1 | 2017 | 22 | 0.150 |
Why?
|
Learning | 1 | 2018 | 79 | 0.150 |
Why?
|
Organizational Objectives | 1 | 2017 | 23 | 0.150 |
Why?
|
Inpatients | 1 | 2017 | 85 | 0.140 |
Why?
|
Data Collection | 2 | 2017 | 180 | 0.140 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 32 | 0.140 |
Why?
|
Reproducibility of Results | 1 | 2018 | 762 | 0.140 |
Why?
|
Patient Readmission | 1 | 2017 | 126 | 0.130 |
Why?
|
Research Design | 1 | 2018 | 313 | 0.130 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 474 | 0.130 |
Why?
|
Health Facility Size | 1 | 2015 | 3 | 0.130 |
Why?
|
Adolescent | 2 | 2017 | 3539 | 0.130 |
Why?
|
Endometrial Neoplasms | 1 | 2015 | 49 | 0.130 |
Why?
|
Cancer Care Facilities | 1 | 2014 | 10 | 0.120 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2014 | 19 | 0.120 |
Why?
|
Primary Health Care | 1 | 2017 | 227 | 0.120 |
Why?
|
Interprofessional Relations | 1 | 2014 | 48 | 0.120 |
Why?
|
American Cancer Society | 1 | 2013 | 3 | 0.110 |
Why?
|
Neoplasms, Second Primary | 1 | 2013 | 16 | 0.110 |
Why?
|
Health Resources | 1 | 2013 | 32 | 0.110 |
Why?
|
Southeastern United States | 1 | 2013 | 79 | 0.110 |
Why?
|
Treatment Outcome | 2 | 2018 | 3306 | 0.110 |
Why?
|
Negotiating | 1 | 2012 | 7 | 0.100 |
Why?
|
Clinical Competence | 1 | 2014 | 333 | 0.100 |
Why?
|
Disease Progression | 1 | 2013 | 594 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 367 | 0.090 |
Why?
|
Healthcare Disparities | 1 | 2012 | 167 | 0.090 |
Why?
|
Managed Care Programs | 1 | 2009 | 41 | 0.090 |
Why?
|
Fluorides, Topical | 2 | 2019 | 6 | 0.080 |
Why?
|
Veterans | 1 | 2009 | 68 | 0.080 |
Why?
|
Disabled Persons | 1 | 2009 | 105 | 0.080 |
Why?
|
Exercise | 1 | 2014 | 672 | 0.080 |
Why?
|
Costs and Cost Analysis | 1 | 2009 | 99 | 0.080 |
Why?
|
Health Expenditures | 1 | 2009 | 66 | 0.080 |
Why?
|
Middle Aged | 6 | 2019 | 11817 | 0.080 |
Why?
|
Medicare | 1 | 2009 | 206 | 0.080 |
Why?
|
Insurance, Health | 1 | 2009 | 95 | 0.070 |
Why?
|
Follow-Up Studies | 1 | 2013 | 2265 | 0.070 |
Why?
|
Adult | 4 | 2019 | 9345 | 0.060 |
Why?
|
Aged | 4 | 2017 | 10301 | 0.050 |
Why?
|
Nurses | 1 | 2020 | 15 | 0.040 |
Why?
|
Dental Clinics | 1 | 2019 | 1 | 0.040 |
Why?
|
Northern Ireland | 1 | 2019 | 1 | 0.040 |
Why?
|
England | 1 | 2019 | 4 | 0.040 |
Why?
|
Australia | 1 | 2019 | 72 | 0.040 |
Why?
|
Focus Groups | 1 | 2019 | 113 | 0.040 |
Why?
|
Organizational Case Studies | 1 | 2018 | 11 | 0.040 |
Why?
|
Genital Neoplasms, Female | 1 | 2018 | 17 | 0.040 |
Why?
|
Physicians | 1 | 2020 | 158 | 0.040 |
Why?
|
Research Personnel | 1 | 2017 | 15 | 0.040 |
Why?
|
Insurance Coverage | 1 | 2017 | 75 | 0.040 |
Why?
|
Poverty | 1 | 2017 | 111 | 0.040 |
Why?
|
Forecasting | 1 | 2017 | 143 | 0.030 |
Why?
|
Research | 1 | 2017 | 74 | 0.030 |
Why?
|
Patient Discharge | 1 | 2017 | 188 | 0.030 |
Why?
|
Adaptation, Psychological | 1 | 2016 | 138 | 0.030 |
Why?
|
Hospitalization | 1 | 2018 | 470 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 353 | 0.030 |
Why?
|
Prospective Studies | 1 | 2017 | 2282 | 0.020 |
Why?
|
Time Factors | 1 | 2016 | 2149 | 0.020 |
Why?
|
Insurance Claim Review | 1 | 2009 | 27 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2016 | 3990 | 0.020 |
Why?
|
Quality of Life | 1 | 2014 | 946 | 0.020 |
Why?
|
Sex Factors | 1 | 2009 | 663 | 0.020 |
Why?
|
Age Factors | 1 | 2009 | 1188 | 0.020 |
Why?
|
Cohort Studies | 1 | 2009 | 1817 | 0.020 |
Why?
|